Clinical trial
A Phase 2b Randomized, Double-blind Trial Comparing HDV-Insulin Lispro Versus Insulin Lispro Alone in Adults With Type 1 Diabetes Receiving Insulin Degludec
NCT06238778 is registered in ClinicalTrials.gov with Diasome Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2b Randomized, Double-blind Trial Comparing HDV-Insulin Lispro Versus Insulin Lispro Alone in Adults With Type 1 Diabetes Receiving Insulin Degludec
- Lead sponsor
- Diasome Pharmaceuticals
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 28, 2023
- Completion date
- December 16, 2025
- Enrollment
- 227 (actual)
- Sites
- 27
Conditions
As the registry lists them; a condition with its own page is linked.